PharmiWeb22m
Straumann Group announces Executive Management Board changes
PersonnelStraumann Group announces Executive Management Board changes 26.02.2025 / 07:00 CET/CESTBasel, February 26, 2025: Today the Straumann Group announces two executive management board changes.
PharmiWeb22m
Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
Annual ResultsGerresheimer delivers solid results in the financial year 2024 despite market headwinds 26.02.2025 / 07:00 CET/CESTThe issuer is solely responsible for the content of this ...
PharmiWeb13h
Prostate cancer: HCPs discuss emerging therapies, clinical trials, imaging and AI diagnostics on social media
A new study into the online conversations of healthcare professionals discussing prostate cancer has revealed a strong focus on emerging therapies, the latest clinical trials, AI-driven diagnostics ...
PharmiWeb14h
Global Retinal Biologics Market to Reach USD 41.92 Billion by 2028 at a 11.1% of CAGR
Retinal Biologics MarketThe Retinal Biologics Market generated USD 19.96 billion in revenue in 2021 and is projected to grow ...
PharmiWeb14h
Global Endometriosis Treatment Market to Reach USD 6,297.2 Million by 2035 at a 5.4% of CAGR
Endometriosis Treatment MarketThe global Endometriosis Treatment Market is projected to grow from USD 3,727.4 million in 2025 ...
PharmiWeb14h
Psoriatic Arthritis (PsA) Treatment Market to Reach USD 25,375.6 Million by 2034 at a 7.8% of CAGR
The global Psoriatic Arthritis (PsA) Treatment Market is expected to grow from USD 11,973.7 million in 2024 to USD 25,375.6 ...
PharmiWeb15h
Antimicrobial Susceptibility Testing Market to Reach USD 4.8 Billion by 2035 with a 3.6% of CAGR
Antimicrobial Susceptibility Testing MarketThe global Antimicrobial Susceptibility Testing (AST) Market is projected to grow from USD 3.4 billion in 2025 to USD 4.8 billion by 2035, expanding at a ...
PharmiWeb15h
CMI Media Group unveils inaugural Media Vitals HCP Global research
Healthcare agency CMI Media Group, a WPP company (NYSE: WPP), has unveiled its first ever Media Vitals HCP Global research. The new report provides insights into the media preferences of healthcare ...
PharmiWeb15h
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
PharmiWeb15h
Strong real-world efficacy and safety data with Pepaxti published in the European Journal of Haematology
Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, today announces that a new real-world study on melflufen (melphalan flufenamide, branded in Europe as Pepaxti) plus ...
PharmiWeb15h
Ottimo Pharma Strengthens Leadership Team with Senior Appointments
Ottimo Pharma (“Ottimo”), an innovative biotech company developing one-of-a-kind PD1/VEGFR2 dual pathway antibodies to extend the lives of patients living with cancer, today announces the appointment ...
PharmiWeb15h
CNX Therapeutics appoints Peter Butterfield as Chief Operating Officer
CNX Therapeutics Limited (“CNX Therapeutics”) today announced the appointment of Peter Butterfield as Chief Operating Officer, effective February 19, 2025. Peter brings extensive pharmaceutical and ...